BSE Live
Jan 14, 16:01Prev. Close
1506.70
Open Price
1505.85
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 14, 15:54Prev. Close
1507.80
Open Price
1500.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1517.00 (3)
| Balance Sheet of Ipca Laboratories (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 25.24 | 25.24 | 25.24 | 25.17 | 25.14 | |
| Total Share Capital | 25.24 | 25.24 | 25.24 | 25.17 | 25.14 | |
| Reserves and Surplus | 2,208.09 | 1,956.37 | 1,544.61 | 1,237.04 | 1,028.72 | |
| Total Reserves and Surplus | 2,208.09 | 1,956.37 | 1,544.61 | 1,237.04 | 1,028.72 | |
| Total Shareholders Funds | 2,233.33 | 1,981.61 | 1,569.85 | 1,262.21 | 1,053.86 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 501.40 | 292.12 | 366.21 | 330.18 | 194.62 | |
| Deferred Tax Liabilities [Net] | 174.23 | 147.11 | 130.39 | 93.09 | 80.73 | |
| Other Long Term Liabilities | 3.21 | 0.38 | 0.40 | 0.59 | 1.66 | |
| Long Term Provisions | 17.66 | 14.49 | 12.21 | 8.72 | 5.34 | |
| Total Non-Current Liabilities | 696.50 | 454.10 | 509.21 | 432.58 | 282.35 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 320.98 | 137.96 | 157.14 | 201.36 | 263.35 | |
| Trade Payables | 302.56 | 337.36 | 265.46 | 233.11 | 177.05 | |
| Other Current Liabilities | 234.93 | 251.35 | 165.18 | 172.16 | 99.89 | |
| Short Term Provisions | 35.44 | 54.72 | 41.91 | 28.57 | 36.66 | |
| Total Current Liabilities | 893.91 | 781.39 | 629.69 | 635.20 | 576.95 | |
| Total Capital And Liabilities | 3,823.74 | 3,217.10 | 2,708.75 | 2,330.05 | 1,913.16 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 1,706.39 | 1,285.10 | 1,052.67 | 908.52 | 694.65 | |
| Intangible Assets | 46.57 | 21.01 | 22.66 | 4.30 | 3.17 | |
| Capital Work-In-Progress | 236.29 | 148.63 | 120.99 | 88.45 | 88.16 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 2,019.91 | 1,471.01 | 1,204.50 | 1,007.33 | 792.57 | |
| Non-Current Investments | 81.86 | 28.75 | 21.79 | 42.65 | 48.79 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 118.87 | 124.76 | 88.16 | 76.36 | 37.24 | |
| Other Non-Current Assets | 10.04 | 9.03 | 9.50 | 7.11 | 2.68 | |
| Total Non-Current Assets | 2,230.68 | 1,633.55 | 1,323.95 | 1,133.45 | 881.28 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.15 | 0.15 | 0.15 | 0.15 | |
| Inventories | 916.98 | 838.30 | 733.34 | 663.98 | 462.51 | |
| Trade Receivables | 353.55 | 448.49 | 415.93 | 345.11 | 369.87 | |
| Cash And Cash Equivalents | 113.19 | 69.49 | 54.66 | 9.25 | 8.44 | |
| Short Term Loans And Advances | 46.84 | 65.47 | 49.64 | 33.66 | 60.92 | |
| OtherCurrentAssets | 162.50 | 161.65 | 131.08 | 144.45 | 129.99 | |
| Total Current Assets | 1,593.06 | 1,583.55 | 1,384.80 | 1,196.60 | 1,031.88 | |
| Total Assets | 3,823.74 | 3,217.10 | 2,708.75 | 2,330.05 | 1,913.16 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 415.70 | 549.71 | 220.90 | 207.68 | 287.79 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 354.42 | 416.61 | 366.28 | 373.20 | 221.02 | |
| Stores, Spares And Loose Tools | 6.47 | 7.27 | 11.21 | 13.45 | 14.46 | |
| Trade/Other Goods | 6.47 | 7.27 | 11.21 | 13.45 | 14.46 | |
| Capital Goods | 156.97 | 98.67 | 41.04 | 52.97 | 38.17 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 170.84 | 199.00 | 158.30 | 132.01 | 87.97 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 1,662.40 | 1,983.62 | 1,667.02 | 1,353.36 | 982.90 | |
| Other Earnings | 12.45 | 21.20 | 9.58 | 7.55 | 3.65 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 20.90 | 20.90 | 20.90 | 20.90 | 20.90 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 18.84 | 0.77 | 0.98 | 1.63 | 6.78 | |
| Non-Current Investments Unquoted Book Value | 78.33 | 37.23 | 32.63 | 51.59 | 60.65 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | 1.28 | 0.36 | 0.30 | 0.49 | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
12.01.2026
11.01.2026
05.12.2025
26.11.2025
Ipca Labs Consolidated September 2025 Net Sales at Rs 2,556.50 crore, up 8.56% Y-o-Y
26.11.2025
Ipca Labs Consolidated September 2025 Net Sales at Rs 2,556.50 crore, up 8.56% Y-o-Y
24.11.2025
Ipca Labs Standalone September 2025 Net Sales at Rs 1,930.32 crore, up 6.59% Y-o-Y
05.09.2025
Ipca Labs Standalone June 2025 Net Sales at Rs 1,746.90 crore, up 11.56% Y-o-Y
10.06.2025
Ipca Labs Standalone March 2025 Net Sales at Rs 1,638.44 crore, up 8.46% Y-o-Y
13.07.2022
Ipca Lab Q1 PAT may dip 41.4% YoY to Rs 179.8 cr: ICICI Direct
08.07.2022
Ipca Laboratories Q1 PAT may dip 36.5% YoY to Rs 194.9 cr: Prabhudas Lilladher
14.04.2022
Ipca Laboratories Q4 PAT may dip 12% YoY to Rs 141.9 cr: Prabhudas Lilladher
13.01.2022
Ipca Laboratories Q3 PAT may dip 32.4% YoY to Rs 179.6 cr: Prabhudas Lilladher